If we make investments that are divorced from certain...
Sputnik V vaccine
Anvisa's board voted unanimously not to approve the Russian...
SputnikĀ V, developed by Moscow's Gamaleya Institute, has proved 91.6%...
NITI Aayog's health member Dr V.K. Paul said that...
The path to a successful vaccine is neither easy...
On September 15, researchers in Greater Noida and New...
For vaccines to work, we need to understand how...












